
Potential new therapy for Glaucoma Sufferers
Tuesday 02 January 2018Researchers at Stanford University are experimenting with a new treatment for Glaucoma which could completely change our thinking about therapy for the condition.
Currently, treatments focus on the symptoms of the disease. This involves relieving the eye pressure that sufferers experience. This can involve eye drops, oral drugs and laser therapy or surgery. The new pathway concentrates on stopping the degeneration in the first place by the use of powerful molecules known as lipoxins.
Researchers have had success testing lipoxins on rodents, and hope to trial the treatment on humans in the near future. The exciting discovery also offers the potential to prevent other neurodegenerative diseases such as Alzheimer’s and Parkinsons.
Sources:
Share your email address and we will keep you up to date as we learn more about light and offer you the best deals.
Comments
Post a comment…
A Serious Blog
News and views from around the world on lighting, eyecare and eye conditions.
Twitter: @seriousreaders
Facebook:facebook.com/seriousreaders
Recent posts
- Will the clocks stop changing? The future of daylight saving time in the UK
- Celebrating World Limerick Day 2025: a rhyme and reason
- Parkinson's Light Therapy: Exploring Hope on World Parkinson's Day
- The effect of light exposure on sleep quality and circadian rhythm
- Essential spring eye care tips for healthy vision and allergy relief
Any more information on provision of Lumigan and Cosopt in non-allergic formulae would be interesting.